摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-phenyl-quinoxaline-5,8-diol | 105975-14-2

中文名称
——
中文别名
——
英文名称
2-phenyl-quinoxaline-5,8-diol
英文别名
2-Phenyl-chinoxalin-5,8-diol;2-Phenylquinoxaline-5,8-diol
2-phenyl-quinoxaline-5,8-diol化学式
CAS
105975-14-2
化学式
C14H10N2O2
mdl
——
分子量
238.246
InChiKey
ZHSXONYAHLZECN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    18
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    66.2
  • 氢给体数:
    2
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    2-phenyl-quinoxaline-5,8-diol 、 在 4-二甲氨基吡啶N,N'-二环己基碳二亚胺 作用下, 以 二氯甲烷 为溶剂, 反应 16.0h, 以3.8 g的产率得到
    参考文献:
    名称:
    POLYMERIZABLE LIQUID CRYSTAL COMPOUND, COMPOSITION, LIQUID CRYSTAL POLYMERIZATION FILM-KIND THEREOF AND USE THEREOF
    摘要:
    提供一种可聚合的液晶化合物,包含该化合物的可聚合液晶组合物以及能够控制色散特性并具有低正色散特性的液晶聚合膜。一种例子是该可聚合液晶化合物由式(1)表示:其中,在式(1)中,G是由喹啉骨架、异喹啉骨架、喹啉骨架或喹嗪骨架组成的基团,A1为1,4-苯基或1,4-环己基,Z1为连接基,m为0至3的整数,R1为含有可聚合基团的基团。
    公开号:
    US20170174992A1
  • 作为产物:
    参考文献:
    名称:
    578.金属的有机配合物形成剂。第二部分 5-羟基和5:8-二羟基喹喔啉及其相关化合物的制备
    摘要:
    DOI:
    10.1039/jr9560002983
点击查看最新优质反应信息

文献信息

  • Polymerizable liquid crystal compound, composition, liquid crystal polymerization film-kind thereof and use thereof
    申请人:JNC CORPORATION
    公开号:US10581022B2
    公开(公告)日:2020-03-03
    An object is to provide a polymerizable liquid crystal compound, a polymerizable liquid crystal composition containing the compound and liquid crystal polymerization film-kind capable of controlling chromatic dispersion characteristics and having low positive chromatic dispersion characteristics. An aspect can be exemplified in which the polymerizable liquid crystal compound is represented by formula (1): in which, in formula (1), G is a group composed of a quinoline skeleton, an isoquinoline skeleton, a quinoxaline skeleton or a quinazoline skeleton, A1 is 1,4-phenylene or 1,4-cyclohexylene, Z1 is a connecting group, m is an integer from 0 to 3, and R1 is a group containing a polymerizable group.
    目的是提供一种可聚合液晶化合物、含有该化合物的可聚合液晶组合物以及能够控制色散特性并具有低正色散特性的液晶聚合膜。 可举例说明的一个方面是,可聚合液晶化合物由式(1)表示: 其中,在式 (1) 中,G 是由喹啉骨架、异喹啉骨架、喹喔啉骨架或喹唑啉骨架组成的基团,A1 是 1,4-亚苯基或 1,4-环己烯,Z1 是连接基团,m 是 0 至 3 的整数,R1 是含有可聚合基团的基团。
  • Cured product, optical member, lens, and compound
    申请人:FUJIFILM Corporation
    公开号:US11396613B2
    公开(公告)日:2022-07-26
    The present invention provides a cured product obtained by curing a curable composition including a compound represented by General Formula 1, in which a birefringence Δn (587 nm) is 0.00≤Δn (587 nm)≤0.01. Pol1-Sp1-L1-Ar-L2-Sp2-Pol2  (General Formula 1) In the formula, Ar represents a divalent group containing a ring structure selected from the group consisting of a quinoxaline ring and a quinazoline ring; L1 and L2 each represent a single bond, —O—, —OC(═O)—, —OC(═O)O—, —OC(═O)NH—, and the like; Sp1 and Sp2 each represent a single bond or a divalent linking group; Pol1 and Pol2 each represent a hydrogen atom or a polymerizable group; and the compound represented by General Formula 1 has at least one polymerizable group. The cured product of the present invention has a small Abbe number (νd) and a large partial dispersion ratio (θg, F), and is therefore useful for production of optical members.
    本发明提供了一种通过对可固化组合物进行固化而获得的固化产物,所述可固化组合物包含由通用式1表示的化合物,其中双折射率Δn (587 nm)满足0.00≤Δn (587 nm)≤0.01。 Pol1-Sp1-L1-Ar-L2-Sp2-PoL2  (通用式1) 在上述式中,Ar表示从喹喔啉环和喹嗪环中选择的包含环结构的二价基团;L1和L2各自表示单键、—O—、—OC(=O)—、—OC(=O)O—、—OC(=O)NH—等;Sp1和Sp2各自表示单键或二价连接基团;Pol1和PoL2各自表示氢原子或可聚合基团;并且由通用式1表示的化合物具有至少一个可聚合基团。本发明的固化产物具有较小的阿贝数(νd)和较大的部分色散比(θg, F),因此在光学元件的生产中具有用途。
  • Lane; Williams, Journal of the Chemical Society, 1958, p. 2983,2985
    作者:Lane、Williams
    DOI:——
    日期:——
  • CURED PRODUCT, OPTICAL MEMBER, LENS, AND COMPOUND
    申请人:FUJIFILM Corporation
    公开号:US20210017315A1
    公开(公告)日:2021-01-21
    The present invention provides a cured product obtained by curing a curable composition including a compound represented by General Formula 1, in which a birefringence Δn (587 nm) is 0.00≤Δn (587 nm)≤0.01. Pol 1 -Sp 1 -L 1 -Ar-L 2 -Sp 2 -Pol 2 (General Formula 1) In the formula, Ar represents a divalent group containing a ring structure selected from the group consisting of a quinoxaline ring and a quinazoline ring; L 1 and L 2 each represent a single bond, —O—, —OC(═O)—, —OC(═O)O—, —OC(═O)NH—, and the like; Sp 1 and Sp 2 each represent a single bond or a divalent linking group; Pol 1 and Pol 2 each represent a hydrogen atom or a polymerizable group; and the compound represented by General Formula 1 has at least one polymerizable group. The cured product of the present invention has a small Abbe number (νd) and a large partial dispersion ratio (θg, F), and is therefore useful for production of optical members.
查看更多

同类化合物

()-2-(5-甲基-2-氧代苯并呋喃-3(2)-亚乙基)乙酸乙酯 (双(2,2,2-三氯乙基)) (乙基N-(1H-吲唑-3-基羰基)ethanehydrazonoate) (Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S)-(-)-5'-苄氧基苯基卡维地洛 (S)-(-)-2-(α-(叔丁基)甲胺)-1H-苯并咪唑 (S)-(-)-2-(α-甲基甲胺)-1H-苯并咪唑 (S)-氨氯地平-d4 (S)-8-氟苯并二氢吡喃-4-胺 (S)-4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑 (S)-4-氯-1,2-环氧丁烷 (S)-3-(2-(二氟甲基)吡啶-4-基)-7-氟-3-(3-(嘧啶-5-基)苯基)-3H-异吲哚-1-胺 (S)-2-(环丁基氨基)-N-(3-(3,4-二氢异喹啉-2(1H)-基)-2-羟丙基)异烟酰胺 (SP-4-1)-二氯双(喹啉)-钯 (SP-4-1)-二氯双(1-苯基-1H-咪唑-κN3)-钯 (R,S)-可替宁N-氧化物-甲基-d3 (R,S)-六氢-3H-1,2,3-苯并噻唑-2,2-二氧化物-3-羧酸叔丁酯 (R)-(+)-5'-苄氧基卡维地洛 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-卡洛芬 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (R)-4-异丙基-2-恶唑烷硫酮 (R)-3-甲基哌啶盐酸盐; (R)-2-苄基哌啶-1-羧酸叔丁酯 (N-(Boc)-2-吲哚基)二甲基硅烷醇钠 (N-{4-[(6-溴-2-氧代-1,3-苯并恶唑-3(2H)-基)磺酰基]苯基}乙酰胺) (E)-2-氰基-3-(5-(2-辛基-7-(4-(对甲苯基)-1,2,3,3a,4,8b-六氢环戊[b]吲哚-7-基)-2H-苯并[d][1,2,3]三唑-4-基)噻吩-2-基)丙烯酸 (E)-2-氰基-3-[5-(2,5-二氯苯基)呋喃-2-基]-N-喹啉-8-基丙-2-烯酰胺 (8α,9S)-(+)-9-氨基-七氢呋喃-6''-醇,值90% (6R,7R)-7-苯基乙酰胺基-3-[(Z)-2-(4-甲基噻唑-5-基)乙烯基]-3-头孢唑啉-4-羧酸二苯甲基酯 (6-羟基嘧啶-4-基)乙酸 (6,7-二甲氧基-4-(3,4,5-三甲氧基苯基)喹啉) (6,6-二甲基-3-(甲硫基)-1,6-二氢-1,2,4-三嗪-5(2H)-硫酮) (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5R,Z)-3-(羟基((1R,2S,6S,8aS)-1,3,6-三甲基-2-((E)-prop-1-en-1-yl)-1,2,4a,5,6,7,8,8a-八氢萘-1-基)亚甲基)-5-(羟甲基)-1-甲基吡咯烷-2,4-二酮 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-(4-乙氧基-3-甲基苄基)-1,3-苯并二恶茂) (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氯-2,1,3-苯并噻二唑-4-基)-氨基甲氨基硫代甲酸甲酯一氢碘 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (5-氨基-1,3,4-噻二唑-2-基)甲醇 (4aS-反式)-八氢-1H-吡咯并[3,4-b]吡啶 (4aS,9bR)-6-溴-2,3,4,4a,5,9b-六氢-1H-吡啶并[4,3-B]吲哚 (4S,4''S)-2,2''-环亚丙基双[4-叔丁基-4,5-二氢恶唑] (4-(4-氯苯基)硫代)-10-甲基-7H-benzimidazo(2,1-A)奔驰(德)isoquinolin-7一 (4-苄基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4-甲基环戊-1-烯-1-基)(吗啉-4-基)甲酮 (4-己基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4,5-二甲氧基-1,2,3,6-四氢哒嗪)